A Tale of a Man, a Worm and a Snail (Paperback)

Paperback. Schistosomiasis is Africa's second most common parasitic disease. Less than 20 years ago, over 200 million were infected. In many high-risk areas the Schistosomiasis Control Initiative (SCI) has been helping to tackle the disease by offering treatments to millions of children. This book tells the story of a man, Alan Fenwick, who founded the SCI to control the worms and snails and so improve the lives of many burdened with the disease as well as reducing the numbers infected. Over this period SCI and the Ministries of Health and Education in 16 countries delivered over 220 million treatments. Treatment coverage of up to 75% has been achieved. Widely recognised as a cost-effective and successful intervention, SCI's knock-on effects include improving overall physical health, school attendance and future prospects for millions of people. The authors explore the work and experiences involved in forming, establishing and managing a health intervention system such as the SCI, while describing important lessons for anyone looking to replicate the success. This book covers: - Challenges faced and how the SCI overcame them to achieve its success; - Raising funds to deliver donated medicines; - Development of innovative partnerships; - Cultivation of working relationships and implementation across Africa; - A new model for other Neglected Tropical Disease programmes (NTDs); - Aspects of Alan's life in Africa told with memorable and often humorous anecdotes. A Tale of a Man, a Worm and a Snail is an essential resource for researchers, policymakers, health professionals and students of NTD control. The book is an enlightening, informative and enjoyable read for anyone interested in global health. Schistosomiasis is Africa's second most prevalent infectious disease after malaria and is a neglected tropical disease. This book offers a unique perspective on a successful health initiative that can serve as a model for other diseases. It will be of interest to those working in global health and disease control. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …